Please login to the form below
anxiety
This page shows the latest anxiety news and features for those working in and with pharma, biotech and healthcare.
Moderna CEO makes case for firm’s lofty valuation
Moderna’s record-breaking $604m IPO last year was followed by a steep decline in its shares, which contributed to the anxiety about biotech sector financing overall in 2019, although Bancel
Latest news
-
AstraZeneca wins NICE backing for asthma injection
hold them back from doing many basic daily tasks, lead to psychological problems including anxiety and depression, and leave them in constant fear of a potentially lethal asthma attack.
-
After December slump, what’s in store for biotech in 2019?
Analysts say 2019 could be a "big year for proceeds if not for deal count"
-
As May delays, industry warns again of ‘no-deal’ Brexit
While the letter references alternative supply routes, the lack of detail on these is causing anxiety in the sector.
-
New data keeps AbbVie’s star pipeline therapies on track
There were also significant improvements for AbbVie’s drug over Humira on quality of life measures and over Stelara on anxiety and depression, and risankizumab did better than both comparator drugs
-
Daily Brief: Summit's $12m lifeline, Biohaven's speech anxiety pill, Crescendo's Humabody progress
Biohaven has unveiled early results for its candidate BHV-0223 which it believes could be prescribed to people suffering ‘social anxiety disorder’ and ‘public speaking anxiety’. ... In the pre-specified, primary analysis, BHV-0223 reduced anxiety
More from news
Approximately 1 fully matching, plus 139 partially matching documents found.
Latest Intelligence
-
AstraZeneca’s oncology renaissance
Galbraith is concerned about the rise in reported anxiety and mental health problems in young people, with young women most vulnerable.
-
The Patient Safety Challenge
There were anxieties about how reporting could affect their reputations and career prospects.
-
Finding the patient voice
This data provided the big picture about what motivates people to join clinical trials, their anxieties and their experiences. ... we should communicate with them, depending on their needs and anxieties.
-
Grünenthal's relentless pursuit of relief
The pursuit of pain relief is nowhere near over and many companies and institutions are chasing answers to reduce the impact of chronic pain and its corrosive byproducts: anxiety, fatigue, depression
-
Mining for results
it takes a good amount of their anxiety away,” he explains.
More from intelligence
Approximately 0 fully matching, plus 15 partially matching documents found.
Latest appointments
-
Dr Niall Murphy and Pierre Schwich join Pharnext
Prior to this, Dr Murphy served as a unit leader for a team of scientists collaborating on research in the areas of addition biology, Alzheimer's disease, anxiety, depression and neurotoxicity
-
Turing names Eliseo Salinas as head of R&D
Salinas has played a leading role in numerous programmes for a range of diseases and disorders, with specific focus on central nervous systems (CNS) condition such as depression and anxiety, schizophrenia,
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
Aromatherapy Market : Quantitative Market Analysis, Current and Future Trends, 2016-2026
channel. Medical centers offering therapeutic treatments have initiated promotions for the use of aromatherapy in the treatment of generic ailments such as headaches, anxiety and depression.
-
Artificial Intelligence in Healthcare
Stoking the fires of both patients’ and healthcare professionals’ (HCP) anxiety regarding the implementation of such a monumental system change are the hordes of drug makers who are beating on the
-
World Diabetes Day: Interaction and impact of diabetes on mental health
A longitudinal study of affective and anxiety disorders, depressive affect and diabetes distress in adults with type 2 diabetes. Diabetic medicine, 25(9), pp.1096-1101.
-
Neurodiversity, ADHD and work: Obstacles and opportunities
they generally persist through to adulthood, leading to on average worse educational, occupational, economic, social and relationship outcomes,[3] with higher rates of comorbidities such as mood, anxiety and sleep
-
Apple Watch Series 4: A life-saving tool or just making us more health obsessed?
I was once told that health anxiety (often known as hypochondriasis) is one of the most common types of anxiety. ... by its wearers in a negative fashion - instilling fear and anxiety in many.
More from PMHub
Approximately 0 fully matching, plus 20 partially matching documents found.
Featured jobs
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
-
Associate Director
-
£75, 000-90, 000
-
Account Manager / Account Director
-
Competative
- Account Manager / Senior Account Manager
-
35, 000-40, 000
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
- Senior Account Manager, Rare Diseases – Medical Communications, ...
-
Excellent package
-
Business Director
-
Competitive Salary Offered
-
Senior Account Manager
-
Competitive Salary Offered
-
Senior Medical Writer
-
Salary TBC
- Engagement Expert, Healthcare Brand Communications, London
-
Excellent package
-
Account Director
-
Competitive Salary Offered
-
Medical Writer
-
Salary TBC
- Global Business Development Director – Health Education
-
excellent commission
-
Account Director, Medical Education
-
Salary TBC
- Senior Account Director development role to Business Director, H...
-
Excellent package
Subscribe to our email news alerts
- Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
- Essential collaboration skills training for pharma and healthcare teams launched by Dovetail.
- Evenity back on track with FDA panel blessing in osteoporosis
- NICE gives Lilly’s Verzenios chance to compete with rivals
- J&J’s Erleada cleared for early prostate cancer in Europe
- New faces at Lucid, 90Ten and Page & Page
PMHub
Bedrock Healthcare Communications
Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...
Latest intelligence
- Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
- Healthcare leaders in the European Union should begin preparing for a breakthrough now...
- The UK’s new five-year pricing agreement
- Pharma has agreed to capped growth again - in exchange for uptake promises...
- Digital applications are transforming the market access landscape
- Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Quick links
Infographics
